175 related articles for article (PubMed ID: 27604950)
1. M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.
Wang Q; Zhang X; Han Y; Wang X; Gao G
Sci Rep; 2016 Sep; 6():32736. PubMed ID: 27604950
[TBL] [Abstract][Full Text] [Related]
2. 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
Lodermeyer V; Suhr K; Schrott N; Kolbe C; Stürzel CM; Krnavek D; Münch J; Dietz C; Waldmann T; Kirchhoff F; Goffinet C
Retrovirology; 2013 Oct; 10():111. PubMed ID: 24156545
[TBL] [Abstract][Full Text] [Related]
3. Subcellular Localization of HIV-1
Becker JT; Sherer NM
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
[TBL] [Abstract][Full Text] [Related]
4. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding.
Murakami T; Carmona N; Ono A
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8055-8063. PubMed ID: 32193343
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Exploits the Host Factor RuvB-like 2 to Balance Viral Protein Expression.
Mu X; Fu Y; Zhu Y; Wang X; Xuan Y; Shang H; Goff SP; Gao G
Cell Host Microbe; 2015 Aug; 18(2):233-42. PubMed ID: 26211835
[TBL] [Abstract][Full Text] [Related]
7. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
8. Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity.
Perugi F; Muriaux D; Ramirez BC; Chabani S; Decroly E; Darlix JL; Blot V; Pique C
Mol Biol Cell; 2009 Jan; 20(1):498-508. PubMed ID: 18946087
[TBL] [Abstract][Full Text] [Related]
9. Single molecule fate of HIV-1 envelope reveals late-stage viral lattice incorporation.
Buttler CA; Pezeshkian N; Fernandez MV; Aaron J; Norman S; Freed EO; van Engelenburg SB
Nat Commun; 2018 May; 9(1):1861. PubMed ID: 29748537
[TBL] [Abstract][Full Text] [Related]
10. Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.
Jaber T; Bohl CR; Lewis GL; Wood C; West JT; Weldon RA
J Virol; 2009 Oct; 83(20):10448-59. PubMed ID: 19640976
[TBL] [Abstract][Full Text] [Related]
11. IQGAP1 Negatively Regulates HIV-1 Gag Trafficking and Virion Production.
Sabo Y; de Los Santos K; Goff SP
Cell Rep; 2020 Mar; 30(12):4065-4081.e4. PubMed ID: 32209469
[TBL] [Abstract][Full Text] [Related]
12. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Neil SJ; Zang T; Bieniasz PD
Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
[TBL] [Abstract][Full Text] [Related]
13. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
[TBL] [Abstract][Full Text] [Related]
14. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
Karczewski MK; Strebel K
J Virol; 1996 Jan; 70(1):494-507. PubMed ID: 8523563
[TBL] [Abstract][Full Text] [Related]
15. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.
Monde K; Contreras-Galindo R; Kaplan MH; Markovitz DM; Ono A
J Virol; 2012 Oct; 86(20):11194-208. PubMed ID: 22855497
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
Van Damme N; Guatelli J
Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
[TBL] [Abstract][Full Text] [Related]
17. Cellular Antiviral Factors that Target Particle Infectivity of HIV-1.
Goffinet C
Curr HIV Res; 2016; 14(3):211-6. PubMed ID: 26674651
[TBL] [Abstract][Full Text] [Related]
18. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.
Tada T; Zhang Y; Koyama T; Tobiume M; Tsunetsugu-Yokota Y; Yamaoka S; Fujita H; Tokunaga K
Nat Med; 2015 Dec; 21(12):1502-7. PubMed ID: 26523972
[TBL] [Abstract][Full Text] [Related]
19. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
[TBL] [Abstract][Full Text] [Related]
20. Roles of the interactions between Env and Gag proteins in the HIV-1 replication cycle.
Murakami T
Microbiol Immunol; 2008 May; 52(5):287-95. PubMed ID: 18557900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
